Skip to content

Survey shows less than 25% getting ARVS in many countries, despite growth in international funding

HIV treatment must lead transformation of primary health care in developing world

Patients staying on first-line HIV treatment combinations for longer

Security, food, healthcare and transport barriers to adherence in conflict zone

Herpes drug has direct anti-HIV effect, could offer cheap addition to antiretroviral therapy for developing world

Study shows patients in their 30s at time of HIV infection have best response to HIV therapy

Brazil rejects tenofovir patent

Poor results using non-medical HIV counsellors to screen for treatment eligibility in Malawi

Raltegravir may cause temporary worsening of pre-existing depression